Crescent Biopharma (CBIO) executive Pinkas received 142,474 Stock Option (Right to Buy)
Stocks in this Quantisnow insightHealth Care
Insider transactions reported
Jan Pinkas (Chief Scientific Officer at Crescent Biopharma Inc., CBIO) reported that they received 142,474 Stock Option (Right to Buy) on Jul 16, 2025.
- Reporting person
- Pinkas Jan
- Role
- Chief Scientific Officer
Options and other derivatives
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Jul 16, 2025 | Grant or award (A) | Stock Option (Right to Buy)On 142,474 Ordinary Shares1 | +142,474 | - | - | 142,474 direct |
Holdings before and after
- Stock Option (Right to Buy): 0 to 142,474 direct
Footnotes from the filing
- 1. This option will vest as to 25% on July 7, 2026 and in equal monthly installments thereafter through July 7, 2029, subject to the Reporting Person's continued service to the Issuer on each such vesting date.
Transaction codes in this filing
- Grant or award:
- Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
FAQ
What did Pinkas report in this CBIO Form 4?
Jan Pinkas (Chief Scientific Officer at Crescent Biopharma Inc., CBIO) reported that they received 142,474 Stock Option (Right to Buy) on Jul 16, 2025.
What does transaction code A mean on an SEC Form 4?
Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
Historical context for CBIO
Earlier insider filings at CBIO
- Nov 23, 2023Luo Ying acquired 2,840,376 shares (SEC Form 4)
- Nov 23, 2023SEC Form 4 filed by Ye Weiguo
- Nov 23, 2023SEC Form 4 filed by Ma Songjiang
- Nov 23, 2023SEC Form 4 filed by Chen Ruoyu
- Nov 23, 2023Gni Group Ltd. acquired 63,588,119 shares (SEC Form 4)
Quantisnow market dataNASDAQ
CBIO
Crescent Biopharma Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2014
Get push alerts for CBIO
Full CBIO profile on Quantisnow Follow CBIO and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time